|
|
Article: Ampicillin is surrogate for susceptibility of enterococci to imipenem.
- Article from:
- Science Letter
- Article date:
- October 26, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 OCT 26 - (NewsRx.com & NewsRx.net) -- Ampicillin can function as a surrogate for in vitro testing of susceptibility of enterococci to imipenem.
According to a study from the United States, "Imipenem is approved by the U.S. Food and Drug Administration (FDA) for treatment of infections caused by Enterococcus faecalis. However, there are no NCCLS guidelines for testing susceptibility of enterococci against imipenem. To assess whether or not ampicillin or penicillin could be used as a surrogate for broth microdilution (BMD) testing of imipenem versus Enterococcus species, 633 strains of E. faecalis, E. faecium, and other enterococci isolated from blood cultures ...